AI assistant
Sending…
UNIVERSAL HEALTH SERVICES INC — Director's Dealing 2017
Dec 11, 2017
30533_dirs_2017-12-11_14d3006b-9db8-44e2-9f14-f09b57519595.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNIVERSAL HEALTH SERVICES INC (UHS)
CIK: 0000352915
Period of Report: 2017-12-08
Reporting Person: MILLER ALAN B (Director, Chairman and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-08 | Class B Common Stock | M | 140000 | $110.34 | Acquired | 1195933 | Direct |
| 2017-12-08 | Class B Common Stock | F | 100317 | $110.34 | Disposed | 1095616 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-08 | Option To Purchase Class B Common Stock | $53.38 | M | 140000 | Disposed | 2018-01-15 | Class B Common Stock (140000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 14858 | Indirect |
| Class B Common Stock | 22259 | Indirect |
| Class B Common Stock | 62883 | Indirect |
| Class B Common Stock | 55763 | Indirect |
| Class B Common Stock | 14858 | Indirect |
| Class B Common Stock | 22259 | Indirect |
| Class B Common Stock | 62883 | Indirect |
| Class B Common Stock | 14858 | Indirect |
| Class B Common Stock | 22259 | Indirect |
| Class B Common Stock | 62883 | Indirect |
| Class B Common Stock | 10810 | Indirect |
| Class B Common Stock | 59900 | Indirect |
| Class B Common Stock | 55763 | Indirect |
Footnotes
F1: Option vested ratably on 1/16/2017.
More from UNIVERSAL HEALTH SERVICES INC
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 7
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Mar 30